Biopta
www.reprocell.comBiopta (now REPROCELL Europe) is the leading contract research organization offering human fresh tissue testing. Based in Glasgow, UK, REPROCELL Europe has been providing contract research services to the pharmaceutical industry since 2002. Our expertise covers all areas of human tissue research - including sourcing, handling, and experimenting - allowing us to act as your “Human Tissue Research Department”. Using ethically sourced and obtained human tissues, we provide early indications of drug safety, efficacy and absorption. Our human ex vivo pharmacology models bridge the gap between animal in vivo data and the clinic. • Human safety assays: predict adverse effects in healthy human tissues • Human efficacy assays: use diseased human tissues to demonstrate drug efficacy • Human absorption assays: use respiratory and gastrointestinal tissues to predict drug absorption This invaluable human data is available during early discovery and development phases and helps reduce the number of compounds which fail in the later stages of drug development. Find out more by visiting our website.
Read moreBiopta (now REPROCELL Europe) is the leading contract research organization offering human fresh tissue testing. Based in Glasgow, UK, REPROCELL Europe has been providing contract research services to the pharmaceutical industry since 2002. Our expertise covers all areas of human tissue research - including sourcing, handling, and experimenting - allowing us to act as your “Human Tissue Research Department”. Using ethically sourced and obtained human tissues, we provide early indications of drug safety, efficacy and absorption. Our human ex vivo pharmacology models bridge the gap between animal in vivo data and the clinic. • Human safety assays: predict adverse effects in healthy human tissues • Human efficacy assays: use diseased human tissues to demonstrate drug efficacy • Human absorption assays: use respiratory and gastrointestinal tissues to predict drug absorption This invaluable human data is available during early discovery and development phases and helps reduce the number of compounds which fail in the later stages of drug development. Find out more by visiting our website.
Read moreCountry
City (Headquarters)
Glasgow
Industry
Employees
11-50
Founded
2002
Estimated Revenue
$10,000,000 to $50,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Study Director
Email ****** @****.comPhone (***) ****-****Office Manager
Email ****** @****.comPhone (***) ****-****Research Technologist
Email ****** @****.comPhone (***) ****-****
Technologies
(48)